BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32061880)

  • 1. Prospective multicentre study on azole resistance in Aspergillus isolates from surveillance cultures in haematological patients in Italy.
    Prigitano A; Esposto MC; Grancini A; Passera M; Paolucci M; Stanzani M; Sartor A; Candoni A; Pitzurra L; Innocenti P; Micozzi A; Cascio GL; Delia M; Mosca A; Mikulska M; Ossi C; Fontana C; Pizzolante M; Gelmi M; Cavanna C; Lallitto F; Amato G; Vella A; Pagano L; Bandettini R; De Lorenzis G; Cogliati M; Romanò L; Tortorano A
    J Glob Antimicrob Resist; 2020 Sep; 22():231-237. PubMed ID: 32061880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azole resistance in Aspergillus isolates by different types of patients and correlation with environment - An Italian prospective multicentre study (ARiA study).
    Prigitano A; Esposto MC; Grancini A; Biffi A; Innocenti P; Cavanna C; Lallitto F; Mollaschi EMG; Bandettini R; Oltolini C; Passera M; De Lorenzis G; Sargolzaei M; Crespan M; Cogliati M; Tortorano AM; Romanò L
    Mycoses; 2021 May; 64(5):528-536. PubMed ID: 33438319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspergillus species collected from environmental air samples in Portugal-molecular identification, antifungal susceptibility and sequencing of cyp51A gene on A. fumigatus sensu stricto itraconazole resistant.
    Monteiro C; Pinheiro D; Maia M; Faria MA; Lameiras C; Pinto E
    J Appl Microbiol; 2019 Apr; 126(4):1140-1148. PubMed ID: 30735287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients.
    Fischer J; van Koningsbruggen-Rietschel S; Rietschel E; Vehreschild MJ; Wisplinghoff H; Krönke M; Hamprecht A
    J Antimicrob Chemother; 2014 Jun; 69(6):1533-6. PubMed ID: 24486872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Azole Resistance and TR
    Güngör Ö; Sampaio-Maia B; Amorim A; Araujo R; Erturan Z
    Mycopathologia; 2018 Dec; 183(6):913-920. PubMed ID: 30187246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 2013.
    Parent-Michaud M; Dufresne PJ; Fournier E; Folch B; Martineau C; Moreira S; Doucet N; De Repentigny L; Dufresne SF
    J Antimicrob Chemother; 2020 Apr; 75(4):849-858. PubMed ID: 31891387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species distribution and antifungal susceptibility of clinical Aspergillus isolates: A multicentre study in Taiwan, 2016-2020.
    Wang HC; Hsieh MI; Choi PC; Wu WL; Wu CJ;
    Mycoses; 2023 Aug; 66(8):711-722. PubMed ID: 37186489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain.
    Escribano P; Rodríguez-Sánchez B; Díaz-García J; Martín-Gómez MT; Ibáñez-Martínez E; Rodríguez-Mayo M; Peláez T; García-Gómez de la Pedrosa E; Tejero-García R; Marimón JM; Reigadas E; Rezusta A; Labayru-Echeverría C; Pérez-Ayala A; Ayats J; Cobo F; Pazos C; López-Soria L; Alastruey-Izquierdo A; Muñoz P; Guinea J;
    Clin Microbiol Infect; 2021 Aug; 27(8):1170.e1-1170.e7. PubMed ID: 33010446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends on
    Sabino R; Gonçalves P; Martins Melo A; Simões D; Oliveira M; Francisco M; Viegas C; Carvalho D; Martins C; Ferreira T; Toscano C; Simões H; Veríssimo C
    J Fungi (Basel); 2021 Jan; 7(1):. PubMed ID: 33418997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece: detection of pan-azole resistance associated with the TR46/Y121F/T289A cyp51A mutation.
    Siopi M; Rivero-Menendez O; Gkotsis G; Panara A; Thomaidis NS; Alastruey-Izquierdo A; Pournaras S; Meletiadis J
    J Antimicrob Chemother; 2020 Nov; 75(11):3181-3188. PubMed ID: 32814940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of olorofim against Aspergillus fumigatus sensu lato clinical isolates: activity is retained against isolates showing resistance to azoles and/or amphotericin B.
    Escribano P; Gómez A; Reigadas E; Muñoz P; Guinea J;
    Clin Microbiol Infect; 2022 Sep; 28(9):1291.e7-1291.e10. PubMed ID: 35597509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective multicenter surveillance of clinically isolated Aspergillus species revealed azole-resistant Aspergillus fumigatus isolates with TR34/L98H mutation in the Kyoto and Shiga regions of Japan.
    Tsuchido Y; Tanaka M; Nakano S; Yamamoto M; Matsumura Y; Nagao M
    Med Mycol; 2019 Nov; 57(8):997-1003. PubMed ID: 30690480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phenotypic and Genotypic Evaluation of Azole Resistance in Aspergillus fumigatus Isolates from Clinical and Environmental Specimens].
    Doğan Ö; Gülmez D; Arıkan Akdağlı S
    Mikrobiyol Bul; 2020 Apr; 54(2):291-305. PubMed ID: 32723284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azole-resistant Aspergillus fumigatus is highly prevalent in the environment of Vietnam, with marked variability by land use type.
    Duong TN; Le TV; Tran KH; Nguyen PT; Nguyen BT; Nguyen TA; Nguyen HP; Nguyen BT; Fisher MC; Rhodes J; Marks G; Fox GJ; Chen SC; Walsh MG; Barrs VR; Talbot J; Halliday CL; Sorrell TC; Day JN; Beardsley J
    Environ Microbiol; 2021 Dec; 23(12):7632-7642. PubMed ID: 34232541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azole-resistant Aspergillus fumigatus in the Italian environment.
    Prigitano A; Esposto MC; Romanò L; Auxilia F; Tortorano AM
    J Glob Antimicrob Resist; 2019 Mar; 16():220-224. PubMed ID: 30367993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
    Talbot JJ; Subedi S; Halliday CL; Hibbs DE; Lai F; Lopez-Ruiz FJ; Harper L; Park RF; Cuddy WS; Biswas C; Cooley L; Carter D; Sorrell TC; Barrs VR; Chen SC
    J Antimicrob Chemother; 2018 Sep; 73(9):2347-2351. PubMed ID: 29846581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.
    Pontes L; Beraquet CAG; Arai T; Pigolli GL; Lyra L; Watanabe A; Moretti ML; Schreiber AZ
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
    Dellière S; Verdurme L; Bigot J; Dannaoui E; Senghor Y; Botterel F; Fekkar A; Bougnoux ME; Hennequin C; Guitard J
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental Isolates of Multi-Azole-Resistant
    Trovato L; Scalia G; Domina M; Oliveri S
    J Fungi (Basel); 2018 Dec; 4(4):. PubMed ID: 30563198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
    Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
    J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.